Prescription of Second-Generation Antipsychotics: Responding to Treatment Risk in Real-World Practice
Hermes ED, Sernyak MJ, Rosenheck RA. Prescription of Second-Generation Antipsychotics: Responding to Treatment Risk in Real-World Practice. Psychiatric Services 2013, 64: 238-244. PMID: 23241613, DOI: 10.1176/appi.ps.201200183.Peer-Reviewed Original ResearchMeSH KeywordsAgedAntipsychotic AgentsChoice BehaviorHealth Care SurveysHealth Knowledge, Attitudes, PracticeHumansMetabolic SyndromeMiddle AgedPractice Patterns, Physicians'Risk AssessmentUnited StatesConceptsSecond-generation antipsychoticsProportion of patientsCardiometabolic riskCardiometabolic disordersCardiovascular diseaseSociodemographic dataSingle Veterans Affairs medical centerVeterans Affairs Medical CenterChoice of antipsychoticHigh cardiometabolic riskPatients' sociodemographic dataQuality of careAntipsychotic prescribedReal-world practicePsychiatric providersTreatment decisionsMedical CenterTreatment risksComorbid diagnosesPatientsAntipsychoticsSignificant associationModerate riskNew prescriptionsProvider sensitivity